| Ticker Symbol | Entity Name | Form Type | Access Number | Period | As Of Date | Filing Date | Institution Name | CIK | Name of Issuer | Title of Class | CUSIP | Value | SHRS or PRN Amount | SHRS or PRN Type | PUT_CALL | Investment Discretion | Other Manager | Voting Authority Sole | Voting Authority Shared | Voting Authority None | Date Added | Date Updated | Company Name | Sector | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| nasdaq:axsm | nasdaq:axsm Shareholders | 13F-HR | 0001567619-22-010940 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | CREDIT SUISSE AG/ | 824468 | Axsome Therapeutics Inc | COM | 05464T104 | 1152 | 27836 | SH | DFND | 4 | 27836 | 0 | 0 | May 17th, 2022 01:56AM | May 17th, 2022 01:56AM | Axsome Therapeutics | |||
| nasdaq:axsm | nasdaq:axsm Shareholders | 13F-HR | 0001567619-22-010940 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | CREDIT SUISSE AG/ | 824468 | Axsome Therapeutics Inc | COM | 05464T104 | 29 | 700 | SH | DFND | 13 | 700 | 0 | 0 | May 17th, 2022 01:56AM | May 17th, 2022 01:56AM | Axsome Therapeutics | |||
| nasdaq:axsm | nasdaq:axsm Shareholders | 13F-HR | 0001567619-22-010940 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | CREDIT SUISSE AG/ | 824468 | Axsome Therapeutics Inc | COM | 05464T104 | 0 | 3 | SH | DFND | 12 | 3 | 0 | 0 | May 17th, 2022 01:56AM | May 17th, 2022 01:56AM | Axsome Therapeutics | |||
| nasdaq:axsm | nasdaq:axsm Shareholders | 13F-HR | 0001567619-22-010940 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | CREDIT SUISSE AG/ | 824468 | Axsome Therapeutics Inc | COM | 05464T104 | 661 | 15964 | SH | DFND | 11 | 15964 | 0 | 0 | May 17th, 2022 01:56AM | May 17th, 2022 01:56AM | Axsome Therapeutics | |||
| nasdaq:axsm | nasdaq:axsm Shareholders | 13F-HR | 0001567619-22-010940 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | CREDIT SUISSE AG/ | 824468 | Axsome Therapeutics Inc | COM | 05464T104 | 69 | 1656 | SH | DFND | 0 | 0 | 1656 | May 17th, 2022 01:56AM | May 17th, 2022 01:56AM | Axsome Therapeutics | ||||
| nasdaq:axsm | nasdaq:axsm Shareholders | 13F-HR | 0001567619-22-010852 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | ROYAL BANK OF CANADA | 1000275 | AXSOME THERAPEUTICS INC | COM | 05464T104 | 71 | 1708 | SH | SOLE | 1708 | 0 | 0 | May 17th, 2022 01:55AM | May 17th, 2022 01:55AM | Axsome Therapeutics | ||||
| nasdaq:axsm | nasdaq:axsm Shareholders | 13F-HR | 0001567619-22-010852 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | ROYAL BANK OF CANADA | 1000275 | AXSOME THERAPEUTICS INC | COM | 05464T104 | 29 | 712 | SH | DFND | 5 | 12 | 700 | 0 | May 17th, 2022 01:55AM | May 17th, 2022 01:55AM | Axsome Therapeutics | |||
| nasdaq:axsm | nasdaq:axsm Shareholders | 13F-HR | 0001567619-22-010852 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | ROYAL BANK OF CANADA | 1000275 | AXSOME THERAPEUTICS INC | COM | 05464T104 | 142 | 3442 | SH | DFND | 3 | 3345 | 0 | 97 | May 17th, 2022 01:55AM | May 17th, 2022 01:55AM | Axsome Therapeutics | |||
| nasdaq:axsm | nasdaq:axsm Shareholders | 13F-HR | 0001567619-22-010822 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | BANK OF AMERICA CORP /DE/ | 70858 | AXSOME THERAPEUTICS INC | COM | 05464T104 | 767 | 18527 | SH | DFND | 43, 01 | 0 | 0 | 18527 | May 17th, 2022 01:54AM | May 17th, 2022 01:54AM | Axsome Therapeutics | |||
| nasdaq:axsm | nasdaq:axsm Shareholders | 13F-HR | 0001567619-22-010822 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | BANK OF AMERICA CORP /DE/ | 70858 | AXSOME THERAPEUTICS INC | COM | 05464T104 | 298 | 7208 | SH | DFND | 43 | 0 | 0 | 7208 | May 17th, 2022 01:54AM | May 17th, 2022 01:54AM | Axsome Therapeutics |